Sanofi Diet Drug Gets Raves, Caution from Doctors
140691
At a time when the drug industry is being pounded with recalls and government investigations while turning out few major new drugs, French drugmaker Sanofi-Aventis appears to have a big winner on its hands.
428365
Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat sinusitis and bronchitis, U.S. officials warned on Monday, saying the controversial drug was too risky to treat those diseases.
602553
U.S. lawmakers criticized the Food  and Drug Administration's monitoring of the risks of a  Sanofi-Aventis antibiotic and some other prescription drugs on  Tuesday.
448727
Pharmaceutical group Sanofi-Synthelabo said it had increased net profit in the first half of the year by 20.6 percent from the same period last year to 1.138 billion euros (1.38 billion dollars).
542334
Galvus, a diabetes drug produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety issues.
542917
Sanofi-Aventis's  Acomplia pill  can significantly improve blood sugar levels in patients with  type 2 diabetes while also reducing their weight, clinical  trial data sponsored by the French drugmaker showed on Tuesday.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
298048
Eli Lilly and Co.&#39;s Alimta lung cancer medicine was as effective as Sanofi-Aventis SA&#39;s Taxotere treatment while causing fewer serious side effects in patients with advanced lung tumors, according to a study.
675633
Sanofi-Aventis SA on Thursday said revenue rose 10.7 percent in the third quarter, as the company posted its first results since its creation from a tie-up between two French drug makers.
266489
A new drug from Sanofi-Aventis reduced  significantly episodes of atrial fibrillaton or irregular heart  beat in two clinical studies released on Sunday.
89817
A U.S. law firm plans to file a lawsuit seeking class-action status against Sanofi-Aventis  on behalf of shareholders, alleging the pharmaceuticals group hid the side-effects of its anti-obesity drug Acomplia, French daily Les Echos reported.
364253
PARIS Sanofi-Aventis shares rose Monday after the French-German drugmaker reported a clinical study showing its experimental anti-obesity drug succeeded in helping people lose weight.
88225
Drug makers Pfizer Inc. and Sanofi-Aventis on Tuesday posted positive results from mid-stage trials of an inhaled insulin product for diabetics.
455559
Doctors researching breast cancer say a new drug has had "exciting" results.
712157
Sanofi-Aventis's  Acomplia pill can significantly improve blood sugar levels in patients with type 2 diabetes while also reducing their weight, clinical trial data sponsored by the French drugmaker showed on Tuesday.
745892
Sanofi-Aventis said on Friday that  U.S. regulators had approved wider use for its colon cancer  drug Eloxatin, lifting shares in the world's third-largest  pharmaceuticals group.
425576
Sanofi-Aventis SA&#39;s obesity pill  Acomplia faces a tough review from European drug safety experts  this week, with data suggesting officials see issues over the  drug&#39;s link with suicidal thoughts.